FBL3B Activators
FBL3B activators encompass a range of chemical compounds that work through different mechanisms to enhance the protein's activity. Forskolin, by increasing cAMP levels, indirectly facilitates FBL3B activation via PKA-dependent phosphorylation pathways. This mechanism is bolstered by IBMX and db-cAMP, which also elevate intracellular cAMP, reinforcing PKA activity and its influence on FBL3B. Calcium signaling is another pivotal pathway for FBL3B activation; both A23187 and Ionomycin raise intracellular calcium levels, which might activate calcium-dependent protein kinases capable of phosphorylating and enhancing FBL3B activity. The role of PKC is highlighted by PMA, which activates PKC, and, if FBL3B is a substrate, could lead to its functional enhancement. Additionally, ZnCl2 and Spermine indirectly affect the protein by modulating ionic concentrations and cellular signaling, potentially impacting FBL3B's activity if it is sensitive to such environmental changes.
Staurosporine, although a broad kinase inhibitor, can in specific conditions selectively tweak the cellular kinase activity, potentially allowing pathways that lead to FBL3B activation. The inhibition of protein phosphatases by Okadaic Acid results in a net increase in protein phosphorylation, which could indirectly result in the enhanced activity of FBL3B if it is regulated by phosphorylation status. Modulation of the PI3K and MAPK pathways by LY294002 and U0126, respectively, can lead to an upregulation of alternate pathways or compensatory mechanisms that may enhance FBL3B activity. These activators work collectively, manipulating intracellular signaling landscapes to favor the functional activation of FBL3B without directly upregulating its expression or acting as direct ligands, thus highlighting the intricate web of cellular signaling and its potential for targeted protein activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, which increases cyclic AMP (cAMP) levels in cells. Elevated cAMP activates protein kinase A (PKA), which can then phosphorylate target proteins, potentially leading to the activation of FBL3B through phosphorylation-dependent conformational changes or interactions that enhance its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels. The increase in calcium can activate calcium-dependent protein kinases, such as CaMKII, which may then phosphorylate and activate FBL3B if its activity is regulated by calcium-dependent phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC, once activated, can phosphorylate a wide range of substrates, potentially including FBL3B, if it is a PKC substrate, thereby enhancing FBL3B's functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, similar to A23187. Elevated calcium can activate a cascade of calcium-dependent kinases that may target FBL3B to enhance its functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation in the cell. This can enhance PKA and PKG activity, which may subsequently phosphorylate and activate FBL3B if it is under control of cAMP/cGMP-dependent signaling. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins by preventing their dephosphorylation. This could lead to the activation of FBL3B if its activity is enhanced by phosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Db-cAMP is a cell-permeable cAMP analog that activates PKA. PKA, in turn, can phosphorylate and activate proteins, potentially leading to the activation of FBL3B through PKA-dependent pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor, but at low concentrations, it can act more selectively. This can lead to a shift in kinase activity in the cell, potentially indirectly activating FBL3B through altered phosphorylation signaling networks. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to altered signaling downstream of PI3K, which may include activation of compensatory pathways that could enhance the activity of FBL3B through indirect effects on cellular signaling. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions are essential cofactors for many enzymes and can modulate the activity of various signaling proteins. Zinc may enhance the activity of FBL3B if it requires zinc as a cofactor or is modulated by zinc-mediated signaling. | ||||||